Register for email alerts and news feeds:
This journal | BMJ Group
rss
Gut 1985;26:1306-1311; doi:10.1136/gut.26.12.1306
Copyright © 1985 BMJ Publishing Group Ltd & British Society of Gastroenterology.

Circulating human leucocyte elastase in patients with inflammatory bowel disease.

E O Adeyemi, S Neumann, V S Chadwick, H J Hodgson, M B Pepys

The plasma concentration of human leucocyte elastase (HLE), measured by enzyme immunoassay as the complex with alpha 1-proteinase inhibitor, was determined in 94 patients with active and inactive inflammatory bowel disease. In Crohn's disease and in ulcerative colitis human leucocyte elastase levels were raised significantly above normal when the disease was active, and fell on remission. The mean human leucocyte elastase level in 31 cases of active Crohn's disease was significantly greater than the mean human leucocyte elastase level in 23 patients with active ulcerative colitis (p = 0.013). The values of human leucocyte elastase correlated significantly with Crohn's disease activity index scores (p = 0.05) and with the circulating concentration of C-reactive protein (p less than 0.05 and p less than 0.01 for ulcerative colitis and Crohn's disease respectively), but not with the erythrocyte sedimentation rate. These results indicate that the concentration of human leucocyte elastase in the plasma of patients with inflammatory bowel disease reflects the activity of their intestinal disease and suggest that serial measurements of human leucocyte elastase may be useful in the assessment and clinical management of these conditions.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Kapui, Z., Varga, M., Urban-Szabo, K., Mikus, E., Szabo, T., Szeredi, J., Batori, S., Finance, O., Aranyi, P. (2003). Biochemical and Pharmacological Characterization of 2-(9-(2-Piperidinoethoxy)-4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yloxymethyl)-4-(1-methylethyl)-6-methoxy-1,2-benzisothiazol-3(2H)-one-1,1-dioxide (SSR69071), a Novel, Orally Active Elastase Inhibitor. J. Pharmacol. Exp. Ther. 305: 451-459 [Abstract] [Full Text]  
  • Numanami, H., Koyama, S., Sato, E., Haniuda, M., Nelson, D. K., Hoyt, J. C., Freels, J. L., Habib, M. P., Robbins, R. A. (2003). Serine protease inhibitors modulate chemotactic cytokine production by human lung fibroblasts in vitro. Am. J. Physiol. Lung Cell. Mol. Physiol. 284: L882-L890 [Abstract] [Full Text]  
  • Fretzayas, A., Moustaki, M., Gourgiotis, D., Bossios, A., Koukoutsakis, P., Stavrinadis, C. (2000). Polymorphonuclear Elastase as a Diagnostic Marker of Acute Pyelonephritis in Children. Pediatrics 105: 28e-28 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Cardiology Jobs

Gastroenterology Jobs